Physicians' Desk Reference

What Physicians' Desk Reference does

PDR, LLC, operating commercially as Physicians' Desk Reference (PDR), is a privately-held US drug information services company headquartered in Whippany, New Jersey, and a subsidiary of ConnectiveRx. The company operates PDR.net, branded as Prescribers' Digital Reference, a fully searchable web-based platform that delivers FDA-approved drug labeling, product safety alerts, drug communications, and pill identification to credentialed US prescribers (MDs, DOs, NPs, and PAs in full-time patient practice) through free registration. PDR also publishes mobilePDR, a companion mobile application offering one-tap drug lookup, drug-interaction detection, and image-based pill identification, and integrates its drug reference content directly into third-party EHR/EMR and electronic prescribing systems for in-workflow use.

The product portfolio is built around continuously updated FDA-approved drug label content sourced from pharmaceutical sponsors and includes PDR.net, mobilePDR, PDR Drug Communications (electronic delivery of drug alerts, recalls, and approvals), PDR Drug Update Newsletters, browseable Drug Labels, and Product Safety Alerts. Physically, the company also sells book and CD-ROM versions of the reference through the PDR Bookstore (pdrbooks.com) for personal use by individuals not eligible for free digital access. The technology stack is a content-centric web platform with native mobile applications and an OEM/embedded distribution layer into clinical workflows via EHR vendors; no proprietary AI/ML models, patents, or research outputs are disclosed.

Revenue is generated through two streams: recurring pharmaceutical company sponsorships that fund free prescriber access to PDR.net (the dominant revenue stream, with sponsors including Regeneron, Daiichi Sankyo, and Purdue Pharma among others, plus an undisclosed longer-tail sponsor base), and one-time sales of physical books and CD-ROMs through the PDR Bookstore. The go-to-market is sales-led to pharmaceutical manufacturers seeking prescriber reach for safety, REMS, and product communications; end-user (HCP) acquisition is free and registration-gated, supported by ongoing credential verification through an alliance with the American Medical Association.

Name

Physicians' Desk Reference

Legal name

PDR, LLC

Website

https://pdr.net

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

PDR operates a US prescriber-facing drug information platform (PDR.net and mobilePDR) that delivers FDA-approved drug labels, safety alerts, and sponsor REMS communications to physicians, NPs, and PAs free of charge, funded by pharmaceutical sponsorships and operated as a subsidiary of ConnectiveRx.

Ownership category

akta.pro rank

Product category

Drug Information Reference

akta.pro primary industry

Value Dossier & Evidence Generation (AMCP/Global Value Dossier) (HLAIAKAC)

Keywords

• Drug information reference
• Prescriber clinical reference
• FDA-approved drug labels
• Drug safety communications
• Medical reference platform

Headquarters

HQ city

Whippany

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Pharmaceutical Sponsorship: Free access provided to healthcare professionals funded by pharmaceutical company sponsors. Revenue is generated from pharmaceutical companies who sponsor the platform to reach prescribers with drug information and communications.
2. PDR Bookstore Sales: Sale of physical PDR books and CD-ROM versions to individuals not eligible for free digital access. Visit pdrbooks.com for purchases.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Core offering

Physicians' Desk Reference (PDR, LLC) provides a fully searchable digital drug information reference — PDR.net (Prescribers' Digital Reference) — that aggregates FDA-approved prescribing information, drug labels, safety alerts, recalls, REMS communications, and approvals, and delivers them to qualified U.S. prescribers free of charge via pharmaceutical company sponsorship. The platform is paired with the mobilePDR mobile app for on-the-go lookup, drug interaction detection, and pill identification, and is reinforced by PDR Drug Communications and Drug Update Newsletters that push current safety and labeling changes to registered providers.

Product overview

Physicians' Desk Reference offers a platform of drug information products and services for healthcare providers. The core offering is PDR.net (Prescribers' Digital Reference), a fully searchable web platform providing drug labels, safety alerts, and communications. The portfolio includes mobilePDR® as the mobile companion application for on-the-go drug reference, and supplementary communication products including PDR Drug Update Newsletters and Drug Communications that deliver alerts, recalls, and approvals. These products are designed exclusively for credentialed U.S. healthcare providers (MDs, DOs, NPs, and PAs) and are offered free through pharmaceutical company sponsorship.

Differentiator

Problem solved

Functional benefit

Products and services

• PDR.net (Prescribers' Digital Reference) Fully searchable web-based platform providing continuously updated FDA-approved drug prescribing information, drug labels, safety alerts, and drug communications to qualified U.S. prescribers (MDs, DOs, NPs, PAs). Serves as the primary digital channel for accessing the Physicians' Desk Reference and is offered free of charge to credentialed healthcare professionals through pharmaceutical company sponsorship.
• mobilePDR Official mobile application providing access to the most current PDR drug prescribing information with fast one-tap drug lookup, drug interaction detection, and pill identification by picture. Available through the iOS App Store and Google Play Store and intended for registered U.S. prescribers.
• PDR Drug Communications Service that delivers Drug Alerts, Recalls, and Approvals to healthcare providers via electronic inbox notification and centralized online housing on PDR.net, including FDA-required REMS safety communications. Used by pharmaceutical sponsors to reach prescribers with safety information.
• PDR Drug Update Newsletters Email newsletters providing registered healthcare providers with updates on new and changing drug labeling, safety information, and drug recall information to support current prescribing decisions.
• PDR Bookstore (Books and CD-ROMs) Sale of physical PDR book and CD-ROM editions via the PDR Bookstore (pdrbooks.com) for personal use by individuals who are not eligible for free digital access on PDR.net.

Quantifiable outcome

• Drug information accessible anytime on mobile devices
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Pharmaceutical Companies (Sponsors)coreGTM or Marketing PartnerPharmaceutical companies sponsor PDR.net to provide free access to healthcare professionals. These sponsors fund the platform to deliver drug safety information, FDA-required communications, REMS information, and drug approvals directly to prescribers. The sponsorship model allows pharmaceutical companies to reach their target prescriber audience with critical drug information.
• ConnectiveRxcoreStrategic or Co-development PartnerConnectiveRx is affiliated with PDR and appears to be the parent organization. The PDR website and privacy policy reference ConnectiveRx as the controlling entity. Contact information and privacy notices point to ConnectiveRx, suggesting an integrated operating structure.
• Regeneron PharmaceuticalsminorGTM or Marketing PartnerRegeneron sponsors PDR communications to deliver drug alerts for Lynozyfic (Linvoseltamab) to oncologists and hematologists as part of FDA-required REMS safety communications.
• Daiichi SankyominorGTM or Marketing PartnerDaiichi Sankyo sponsors PDR drug communications to deliver Turalio (pexidartinib) safety information to medical and orthopedic oncologists as part of FDA-required REMS program.
• Purdue PharmaminorGTM or Marketing PartnerPurdue Pharma sponsors PDR opioid analgesic communications to deliver drug safety alerts and FDA-required information to physicians, pharmacies, and hospitals regarding opioid products including Kadian, OxyContin, and Butrans.
• Medical SocietiesminorStrategic or Co-development PartnerPDR establishes alliances with medical societies to help keep physician email lists up to date and expand reach among healthcare professional communities.
• American Medical AssociationminorStrategic or Co-development PartnerPDR compares physician information with AMA database to help verify accuracy of subscriber database and credential healthcare professionals for access to restricted products and services.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• DynaMed: EBSCO's evidence-based clinical decision support tool offering drug information alongside disease topics, guidelines, and recommendations. Comparable to PDR as an in-workflow clinical reference used by prescribers but broader in scope.
• Medscape: WebMD's clinical news, drug reference, and CME portal widely used by US physicians. Overlaps with PDR on free, sponsor-supported drug information access for prescribers but covers a much broader clinical content portfolio.

Others

• Cerner Multum (Oracle Health): Drug knowledge base formerly known as Cerner Multum, now part of Oracle Health, integrated into EHR systems for in-workflow drug lookups and interaction checking. Adjacent to PDR as a competing in-workflow drug information source for prescribers.
• First Databank (FDB): Provider of drug knowledge bases and clinical decision support modules that power EHR drug lookups, interaction alerts, and patient education content. Adjacent to PDR as an upstream drug-data enabler embedded in the same EHR workflows PDR targets.

Emerging players

• Drugs.com: Consumer- and professional-facing drug information site providing monographs, interactions, pill identifier, and patient education. Comparable to PDR on drug reference content, but distributed free online with advertising revenue rather than to a credentialed prescriber base.

Direct peers

• Epocrates: Athenahealth's mobile-first drug reference and clinical reference app used by prescribers for drug lookup, interaction checking, and pill identification. Highly comparable to mobilePDR on functionality, audience (US prescribers), and mobile delivery model.
• UpToDate: Wolters Kluwer's flagship evidence-based clinical decision support resource used by physicians at the point of care. Closely comparable to PDR as a trusted, frequently accessed drug and clinical information reference inside physician workflows.
• Merative Micromedex: Merative's hospital-oriented drug and clinical reference suite covering indications, dosing, interactions, and IV compatibility. Directly comparable to PDR as an authoritative drug information source used by prescribers and pharmacists.
• Lexicomp: Wolters Kluwer's clinical drug information reference widely used in hospitals and by prescribers for dosing, administration, and interaction data. Directly comparable to PDR as a clinician-facing drug reference with paid institutional access.
• Clinical Pharmacology: Elsevier-hosted drug information platform offering monographs, interactions, and patient counseling for clinicians and pharmacies. Comparable to PDR as a prescriber-targeted drug reference with sponsored content elements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Physicians' Desk Reference